NeurAxis Inc. (NRXS)
NASDAQ: NRXS
· Real-Time Price · USD
2.28
-0.02 (-0.87%)
At close: Jun 13, 2025, 3:59 PM
2.24
-1.75%
After-hours: Jun 13, 2025, 05:59 PM EDT
-0.87% (1D)
| Bid | 2.25 |
| Market Cap | 21.72M |
| Revenue (ttm) | 2.93M |
| Net Income (ttm) | -8.4M |
| EPS (ttm) | -1.23 |
| PE Ratio (ttm) | -1.85 |
| Forward PE | -10.55 |
| Analyst | n/a |
| Ask | 2.3 |
| Volume | 84,620 |
| Avg. Volume (20D) | 1,592,115 |
| Open | 2.29 |
| Previous Close | 2.30 |
| Day's Range | 2.26 - 2.34 |
| 52-Week Range | 1.33 - 6.20 |
| Beta | 4.21 |
About NRXS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NRXS
Website n/a
3 weeks ago
-19.8%
Neuraxis shares are trading lower. The company ann...
Unlock content with
Pro Subscription
3 weeks ago
+75.77%
Neuraxis shares are trading higher after the company announced it received FDA 510(K) clearance regarding IB-stim for the treatment of pediatric FAP associated with functional dyspepsia and FD related nausea symptoms.
